OBALIX 2,5 MG/ML SOLUCION ORAL
OBALIX 2,5 MG/ML SOLUCION ORAL
Pending
Register Number
82663
Prescription Type
Medicamento Sujeto A Prescripción Médica
Authorization Date
Feb 16, 2018
Dosage Form
SOLUCIÓN ORAL
Route: VÍA ORAL
Product Details
Detailed information about this CIMA AEMPS approved pharmaceutical product.
Basic Information
Key regulatory and product classification details
Regulatory Details
Register Number82663
EMA Approved
No
Drug Classification
✗
Generic
No
✗
Orphan
No
✗
Biosimilar
No
✗
Commercialized
No
CIMA AEMPS Classification
INGREDIENTS (1)
BILASTINAActive
Quantity: 2,5 mg
Name: BILASTINA
ATC CLASSIFICATION (3)
R06A
R06AX
R06AX29